The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories
Issuer Directory


< Previous Page
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
Next Page >

22nd Century is a plant biotechnology company with an important mission: To Reduce the Harm Caused by Smoking. The Company's long-term focus is the research, development, licensing, manufacturing, and worldwide sales and distribution of its important products. 22nd Century ...

View Profile

Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The company is positioned to ...

View Profile

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona ...

View Profile

Ability Pharmaceuticals is a clinical stage drug discovery and development biopharmaceutical company headquartered in Bellaterra (Barcelona), Catalonia, Spain. Ability Pharmaceuticals develops safer human therapeutics to treat cancer and other indications with unmet medical needs ...

View Profile

AccuHealth harnesses the power of mobile technology and the science of the human genome to deliver quality healthcare that is person-centered, accessible, and affordable. AccuHealth's patented health technologies use real time actionable data from individualized health risk assessments, to ...

View Profile

Accurexa is a biotechnology company focused on developing and commercializing novel neurological therapies that can deliver therapeutics directly into specific regions of the brain. Our BranchPoint device was invented to deliver therapeutics, such as stem cells or gene ...

View Profile

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. AcelRx's lead product candidate, ZalvisoTM, is designed to improve the management of moderate-to-severe acute pain in ...

View Profile

Acerus Pharmaceuticals Corporation is a Canadian pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve the patient experience. Acerus markets ESTRACE® in Canada, a product indicated for the ...

View Profile

Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat MDR gram-negative infections. Achaogen is developing plazomicin, Achaogen's lead product candidate, for the treatment of serious urinary ...

View Profile

Actinium Pharmaceuticals, Inc. (ATNM: NYSE MKT) is a public biopharmaceutical company specialized in the development of cancer drugs. The Company’s product candidates are based on its patented technology co-developed with Memorial Sloan Kettering Cancer Center (MSKCC) for combining the cancer ...

View Profile

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United ...

View Profile

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) is driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). We seek to achieve this by modifying the pharmacokinetic (PK) profiles of approved drugs to create novel therapeutics for use alone and in ...

View Profile

(ADMP) is a specialty biopharmaceutical company that provides high quality, low-cost solutions for patients, physicians, and healthcare organizations in the multi-billion dollar therapeutic areas of respiratory disease and allergies. The Company’s lead pipeline product is an epinephrine injection ...

View Profile

AdCare manages, develops, and acquires nursing homes, assisted living facilities, independent living facilities, dementia/Alzheimer’s units, sub-acute units, retirement communities, and ...

View Profile

Addus is a comprehensive provider of home and community-based services that are primarily personal in nature, provided in the home and focused on the dual eligible population. Addus' services include personal care and assistance with activities of daily living, and adult day care. Addus' ...

View Profile

ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised ...

View Profile

Axalimogene filolisbac (ADXS-HPV) is Advaxis’s lead Lm Technology™ immunotherapy candidate for the treatment of HPV-associated cancers and is in clinical trials for three potential indications: invasive cervical cancer, head and neck cancer, and anal cancer. In a completed ...

View Profile

Aeolus is developing a new class of that protect healthy tissue from the damaging effects of oxidative stress. Its first compound, AEOL 10150 is being developed as a medical countermeasure against the pulmonary effects of Acute Radiation Syndrome (“Lung-ARS”) and the ...

View Profile

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company’s product pipeline includes MACRILEN, which completed the Phase 2 trial for use in the diagnosis of adult growth ...

View Profile

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company’s product pipeline includes MACRILEN, which completed the Phase 2 trial for use in the diagnosis of adult growth ...

View Profile

The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics ...

View Profile

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies. Its lead candidate includes AFM13, a natural killer cell bispecific antibody (TandAb) that has completed a Phase I clinical trial for the treatment of certain CD30-positive (CD30+) B- ...

View Profile



< Previous Page
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
Next Page >

© 2017 Stock News Now